These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38706335)

  • 21. Medical Devices to Prevent Opioid Use Disorder: Innovative Approaches to Addressing the Opioid Crisis.
    Comer SD; Dworkin RH; Strain EC
    JAMA Psychiatry; 2019 Apr; 76(4):351-352. PubMed ID: 30785611
    [No Abstract]   [Full Text] [Related]  

  • 22. Harm Reduction in Health Care Settings.
    Chan CA; Canver B; McNeil R; Sue KL
    Med Clin North Am; 2022 Jan; 106(1):201-217. PubMed ID: 34823731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitigating the opioid crisis for the lower extremity provider opioid stewardship programs.
    Smith RG
    Foot (Edinb); 2020 Dec; 45():101708. PubMed ID: 33049426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping Community Opioid Exposure Through Wastewater-Based Epidemiology as a Means to Engage Pharmacies in Harm Reduction Efforts.
    Duvallet C; Hayes BD; Erickson TB; Chai PR; Matus M
    Prev Chronic Dis; 2020 Aug; 17():E91. PubMed ID: 32816660
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and evaluation of a community-based buprenorphine treatment intervention.
    Fox AD; Sohler NL; Frost T; Lopez C; Cunningham CO
    Harm Reduct J; 2017 May; 14(1):23. PubMed ID: 28499432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What Strategies Are Hospitals Adopting to Address the Opioid Epidemic? Evidence From a National Sample of Nonprofit Hospitals.
    Franz B; Cronin CE; Pagan JA
    Public Health Rep; 2021; 136(2):228-238. PubMed ID: 33176117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The opioid crisis should lead pediatric anesthesiologists to a broader vision of opioid stewardship.
    Burgart AM; Char D
    Paediatr Anaesth; 2019 Nov; 29(11):1078-1080. PubMed ID: 31677337
    [No Abstract]   [Full Text] [Related]  

  • 30. Innovations in efforts to expand treatment for opioid use disorder.
    Sigmon SC
    Prev Med; 2019 Nov; 128():105818. PubMed ID: 31445112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid Use Disorder.
    Taylor JL; Samet JH
    Ann Intern Med; 2022 Jan; 175(1):ITC1-ITC16. PubMed ID: 35007147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harm reduction and the opioid crisis: Emerging policy challenges.
    Greer A; Ritter A
    Int J Drug Policy; 2019 Sep; 71():139-141. PubMed ID: 31160155
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review.
    Tetrault JM; Butner JL
    Yale J Biol Med; 2015 Sep; 88(3):227-33. PubMed ID: 26339205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV.
    Voon P; Joe R; Fairgrieve C; Ahamad K
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27402654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medications for addiction treatment initiated from the emergency department: Ethical considerations.
    Marshall KD; Derse AR; Iserson KV; Kluesner N; Vearrier L
    Am J Emerg Med; 2020 Feb; 38(2):343-348. PubMed ID: 31831343
    [No Abstract]   [Full Text] [Related]  

  • 36. Selections of reality: applying Burke's dramatism to a harm reduction program.
    Järvinen M; Miller G
    Int J Drug Policy; 2014 Sep; 25(5):879-87. PubMed ID: 24702965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing Knowledge of Opioid Misuse and Harm Reduction: A Community Partner Collaboration.
    Previti M; Prakash S; Garcia L
    J Allied Health; 2021; 50(3):229-233. PubMed ID: 34495034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.
    Jutras-Aswad D; Le Foll B; Ahamad K; Lim R; Bruneau J; Fischer B; Rehm J; Wild TC; Wood E; Brissette S; Gagnon L; Fikowski J; Ledjiar O; Masse B; Socias ME;
    Am J Psychiatry; 2022 Oct; 179(10):726-739. PubMed ID: 35702828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Misuse: A Global Crisis.
    Hornberger J; Chhatwal J
    Value Health; 2021 Feb; 24(2):145-146. PubMed ID: 33518020
    [No Abstract]   [Full Text] [Related]  

  • 40. Opioid epidemic: lessons learned and updated recommendations for misuse involving prescription versus non-prescription opioids.
    Bedene A; Dahan A; Rosendaal FR; van Dorp ELA
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1081-1094. PubMed ID: 36068971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.